borderline significantp = 0.059
24 Interestingly, the study by Speight et al (2021) showed a borderline significant result ( p = 0.059), 20 and others such as Lameijer et al (2021) and Ajjan et al (2023) found no significant HbA1c difference. 21 , 23 These mixed outcomes could reflect differences in follow-up duration, CGM usage adherence, intervention intensity, and participant characteristics. 25–27 For instan